Intravenous (IV) vitamin C is an alternative cancer treatment which is thought to work differently inside cancer cells than it does in healthy cells. Vitamin C is typically thought of as an anti-oxidant, but in high doses, it becomes a pro-oxidant. This is an important distinction, because cancer cells do not have a mechanism like healthy cells do to resist these oxidative effects.
According to the National Cancer Institute, laboratory studies have shown that high dose IV vitamin C may slow the growth and spread of multiple cancers, including pancreatic, liver, colon, and prostate, among others. Animal studies have revealed that high dose IV vitamin C blocks tumor growth in certain cancers, including pancreatic, prostate, ovarian, and liver cancers, as well as sarcoma and malignant mesothelioma. Other studies have shown that combining IV vitamin C with anticancer therapies such as chemotherapy is beneficial.
In addition to its effect on cancer cells, human studies have shown that IV vitamin C:
- Strengthens the immune system
- Enhances overall quality of life
- Improves physical, mental, and emotional functioning
- Increases energy levels
- Reduces side effects of chemotherapy such as nausea, vomiting, pain, and loss of appetite
Moreover, IV vitamin C has a very low side effect profile, meaning that it is a very well-tolerated treatment overall.
*Note: IV vitamin C has not been approved by the U.S. Food and Drug Administration as a treatment for cancer or any other medical condition.